Lutarewych Michael MD Fort Myers, FL - 33912

Lutarewych Michael MD is categorized under Infectious Disease Specialists in Fort Myers, FL and active since 2008.

Lutarewych Michael MD was established in 2008, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Michael Lutarewych at the company’s single location by writing to 13813 Metro Parkway, Fort Myers, Florida FL 33912 or by phoning (239) 936-1343. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Lutarewych Michael MD
Contact Person: Michael Lutarewych
Address: 13813 Metro Parkway, Fort Myers, Florida 33912
Phone Number: (239) 936-1343
Website Address: imadoctors.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Infectious Disease Specialists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Lutarewych Michael MD was started in 2008 to provide professional Infectious Disease Specialists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Michael Lutarewych for inquiries that concern Lutarewych Michael MD by calling the company number (239) 936-1343, as your correspondence is most welcome. Additionally, the physical location of the single location of Lutarewych Michael MD can be found at the coordinates 26.54181,-81.85263 as well as the street address 13813 Metro Parkway in Fort Myers, Florida 33912.

For its online presence, you may visit Lutarewych Michael MD’s website at imadoctors.com and engage with its social media outlets through on Twitter and on Facebook.